Innovative technology and services for DNA methylation analysis
Our vision is a world where epigenetics helps to tackle the most pressing issues of our time and improves health and wellness for everyone. Here at Cambridge Epigenetix, we believe great things happen when people work together. The biggest leaps in human understanding come from collaboration: when the right specialisms, interests and ambitions combine, the benefits are exponential.
Our new biomarker discovery and development service puts our expertise at your disposal, so we can enrich your understanding, and vice versa.
We have brought together world-leading experts in epigenetics, genomics and the development of next generation sequencing technology. The company is headquartered in Cambridge, UK, and is financed by leading venture capital companies including GV (Google Ventures), Sequoia Capital,Syncona, New Science Ventures and University of Cambridge.